Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China flag China · Delayed Price · Currency is CNY
19.00
+0.92 (5.09%)
Aug 14, 2026, 3:04 PM CST

SHE:300246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
676.95466.39498.72437.03336.55
Short-Term Investments
-263.97322.21342.83-
Cash & Short-Term Investments
676.95730.35820.93779.86336.55
Cash Growth
-7.31%-11.03%5.27%131.72%-30.33%
Accounts Receivable
246.69262.44261.25297.24232.03
Other Receivables
9.9754.7227.5925.2226.26
Receivables
256.67317.16288.84322.46258.29
Inventory
287.82232.07220.37200.57193.5
Other Current Assets
54.254.141.263341.41
Total Current Assets
1,2761,3341,3711,336829.76
Property, Plant & Equipment
957.12911.18888.73737.85584.72
Long-Term Investments
27.5113.848.538.699.83
Goodwill
15.4925.1540.67127.13127.13
Other Intangible Assets
104.36101.6398.0894.5190.51
Long-Term Accounts Receivable
-4.125.59--
Long-Term Deferred Tax Assets
40.6529.1918.132510.48
Long-Term Deferred Charges
42.5639.8140.8525.9131.85
Other Long-Term Assets
58.9740.2162.4383.9735.24
Total Assets
2,5222,4992,5342,4391,720

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
224.01206.49246.8221.26178.44
Accrued Expenses
24.7343.538.8749.5737.35
Short-Term Debt
133.32188.14220.41132.64130.66
Current Portion of Long-Term Debt
264.2840.750.3714.558.06
Current Portion of Leases
-6.656.455.954.47
Current Income Taxes Payable
4.471.983.083.983.37
Current Unearned Revenue
49.1543.7569.3976.0148.08
Other Current Liabilities
102.59144.61135.3499.4386.77
Total Current Liabilities
802.54675.82770.7603.39497.2
Long-Term Debt
306.89388.05284.16252.97205.21
Long-Term Leases
20.3222.1923.6121.468.12
Long-Term Unearned Revenue
167.89106.9450.345.389.32
Long-Term Deferred Tax Liabilities
11.4414.7214.8713.487.25
Other Long-Term Liabilities
1.04-1.81-0.03
Total Liabilities
1,3101,2081,145936.68727.13

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
264.58264.58264.58175.79146.09
Additional Paid-In Capital
408.11408.04408.03504.38-
Retained Earnings
430.53513.04584.48684.82698.15
Treasury Stock
-20.01-20.01---
Comprehensive Income & Other
54.3353.0453.8151.0949.64
Total Common Equity
1,1381,2191,3111,416893.89
Minority Interest
74.6572.4378.0586.1798.49
Shareholders' Equity
1,2121,2911,3891,502992.38
Total Liabilities & Equity
2,5222,4992,5342,4391,720

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
724.8645.72584.99427.57356.52
Net Cash (Debt)
-47.8684.63235.94352.29-19.97
Net Cash Growth
--64.13%-33.03%--
Net Cash Per Share
-0.180.320.891.35-0.09
Filing Date Shares Outstanding
263.9261.6264.58263.68262.22
Total Common Shares Outstanding
263.9261.6264.58263.68219.14
Working Capital
473.1657.87600.7732.5332.56
Book Value Per Share
4.314.664.955.374.08
Tangible Book Value
1,0181,0921,1721,194676.25
Tangible Book Value Per Share
3.864.174.434.533.09
Buildings
-582.36308.84244.21216.58
Machinery
-448.39418.44398.3361.28
Construction In Progress
-127.92365.74263.45155.7